faculty photo

Arupa Ganguly

Professor of Genetics at the Hospital of the University of Pennsylvania
Department: Genetics

Contact information
415 Anatomy Chemistry Building
3620 Hamilton Walk
Philadelphia, PA 19104
Office: 215-898-3122
Fax: 215-573-5940
Lab: 215-573-3020
B.S. (Physics)
Calcutta University, 1974.
M.S. (Physics)
Calcutta University, 1977.
Ph.D. (Biophysics)
University of Calcutta, 1984.
FACMG (Clinical Molecular Genetics)
American Board of Medical Genetics, 1999.
FACMG (Clinical Molecular Genetics)
American Board of Medical Genetics, 2009.
Permanent link

Description of Research Expertise

Genetic Analysis of Predisposition to Retinoblastoma and Uveal Melanoma

Retinoblastoma is a childhood onset ocular cancer caused by mutations in tumor suppressor gene, RB1, present on chromosome 13.
RB1 was the first tumor suppressor gene identified and validated the two hit hypothesis of cancer proposed by Alfred Knudson. The burden of lost eye sight in early childhood is very high with this disease – it has been reduced remarkably in the developed countries, but still is a major concern in developing countries.
Thus there is a need to reduce the burden of blindness by developing treatment modality that will spare the infant eye and vision.

An interesting aspect of RB1 is that this gene is inactivated in half of all known cancer. Yet an individual born with a germline mutation in RB1 gene is predisposed to childhood onset eye tumor and a second cancer that can be osteosarcoma if exposed to radiation or melanoma. This means that the RB1 gene product has a very specific role in the development of the retina – a role that is not shared by other tissues.
However the cell of origin of retinoblastoma is not known. Therefore by studying the gene expression profile of enucleated retinoblastoma tumors we are attempting to answer a few clinical questions like the clinical response to different treatment options, potential for metastasis and molecular basis of other predictive clinical features. In addition we are trying to identify the expression profiles of genes characteristic of the progenitor cells for retina and define at which stage of retinal cell development does the process of tumorigenesis begin.

Another recent direction of research is in defining the molecular basis of uveal melanoma. Uveal melanoma is a rare form of ocular cancer in the Western world and the incidence rate is 1 in 100, 000. A significant observation is that almost half of all identified cases of uveal melanoma develop liver metastasis and die within a very short period after the initial diagnosis. Thus it is a major health care issue. The only prognostic features available at this time are monosomy for chromosome 3 along with alterations on chromosomes 1, 6 and 8 and are associated with bad prognosis. These features suggest an underlying genetic predisposition towards melanomas. Uveal melanoma can be mistaken for congenital nevi and may be undiagnosed or under diagnosed. The goals of this project are: i) To develop a gene signature that will be predictors of metastasis based on investigations on fine needle aspirates. ii) To understand the molecular mechanisms regulating the development of uveal melanomas.

Description of Clinical Expertise

As the Director of the Genetic Diagnostic laboratory, Department of Genetics, I provide clinical molecular genetic testing services for hereditary forms of colon cancer, Li Fraumeni syndrome,Retinoblastoma(RB) and molecular profiling of sporadic uveal mealnoma, Hemophilia A, and Herediatry Hemorrhagic Telangiectasia (HHT or Osler Weber Rendu Syndrome). This laboratory is a reference laboratory for testing RB, HHT and Hemophilia A in the US.
This laboratory is also an ABMG accredited laboratory for training clinical molecular genetics fellows.

In addition, I am involved in a collaboration with Dr, Charles Stanley, Children's Hospital of Philadelphia, to undertsand the molecular genetics of congenital hyperinsulinism (CHI). We have recently identified a novel genomic region linked to autosomal dominant inheritance of CHI.

Selected Publications

Omidakhsh Negar, Bunin Greta R, Ganguly Arupa, Ritz Beate, Kennedy Nola, von Ehrenstein Ondine S, Krause Niklas, Heck Julia E: Parental occupational exposures and the risk of childhood sporadic retinoblastoma: a report from the Children's Oncology Group. Occupational and environmental medicine 75(3): 205-211, Mar 2018.

Bosse Kristopher R, Raman Pichai, Zhu Zhongyu, Lane Maria, Martinez Daniel, Heitzeneder Sabine, Rathi Komal S, Kendsersky Nathan M, Randall Michael, Donovan Laura, Morrissy Sorana, Sussman Robyn T, Zhelev Doncho V, Feng Yang, Wang Yanping, Hwang Jennifer, Lopez Gonzalo, Harenza Jo Lynne, Wei Jun S, Pawel Bruce, Bhatti Tricia, Santi Mariarita, Ganguly Arupa, Khan Javed, Marra Marco A, Taylor Michael D, Dimitrov Dimiter S, Mackall Crystal L, Maris John M: Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma. Cancer cell 32(3): 295-309.e12, Sep 2017.

Vaquero-Garcia Jorge, Lalonde Emilie, Ewens Kathryn G, Ebrahimzadeh Jessica, Richard-Yutz Jennifer, Shields Carol L, Barrera Alejandro, Green Christopher J, Barash Yoseph, Ganguly Arupa: PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma. Investigative ophthalmology & visual science 58(10): 4096-4105, Aug 2017.

Shields Carol L, Say Emil Anthony T, Hasanreisoglu Murat, Saktanasate Jarin, Lawson Brendan M, Landy Jeffrey E, Badami Anjali U, Sivalingam Meera D, Mashayekhi Arman, Shields Jerry A, Ganguly Arupa: Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture. Ophthalmology 124(5): 609-618, May 2017.

Omidakhsh Negar, Ganguly Arupa, Bunin Greta R, von Ehrenstein Ondine S, Ritz Beate, Heck Julia E: Residential Pesticide Exposures in Pregnancy and the Risk of Sporadic Retinoblastoma: A Report From the Children's Oncology Group. American journal of ophthalmology 176: 166-173, Apr 2017.

Ewens Kathryn G, Bhatti Tricia R, Moran Kimberly A, Richards-Yutz Jennifer, Shields Carol L, Eagle Ralph C, Ganguly Arupa: Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. Cancer medicine 6(3): 619-630, Mar 2017.

Ferrara Christine T, Boodhansingh Kara E, Paradies Eleonora, Giuseppe Fiermonte, Steinkrauss Linda J, Topor Lisa Swartz, Quintos Jose Bernardo, Ganguly Arupa, De Leon Diva D, Palmieri Ferdinando, Stanley Charles A: Novel Hypoglycemia Phenotype in Congenital Hyperinsulinism Due to Dominant Mutations of Uncoupling Protein 2. The Journal of clinical endocrinology and metabolism 102(3): 942-949, Mar 2017.

Aggarwala Varun, Ganguly Arupa, Voight Benjamin F: De novo mutational profile in RB1 clarified using a mutation rate modeling algorithm. BMC genomics 18(1): 155, Feb 2017.

Rao Raksha, Pointdujour-Lim Renelle, Ganguly Arupa, Shields Carol L: MULTIFOCAL CHOROIDAL MELANOMA IN A PATIENT WITH GERM LINE BRCA-ASSOCIATED PROTEIN 1 MUTATION. Retinal cases & brief reports 12(1): 1-4, Oct 2016.

Marwaha Nitin, Batanian Jacqueline R, Coppens Jeroen R, Pierson Matthew J, Richards-Yutz Jennifer, Ebrahimzadeh Jessica, Ganguly Arupa, Guzman Miguel A: Subcutaneous melanocytoma mimicking a lipoma: a rare presentation of a rare neoplasm with histological, immunohistochemical, cytogenetic and molecular characterization. Journal of cutaneous pathology 43(12): 1186-1196, Aug 2016.

back to top
Last updated: 09/04/2017
The Trustees of the University of Pennsylvania